Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- DOXY-PEPIndependent statistical analysis of Doxy-Post-exposure Prophylaxis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05853120).
- Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy: Complete Statistical AnalysisIndependent statistical analysis of Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01855360).
- Doxycycline, Temozolomide and Ipilimumab in Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Doxycycline, Temozolomide and Ipilimumab in Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01590082).
- DREAMIndependent statistical analysis of Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- DREAMM 5Independent statistical analysis of Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM): primary endpoint results, effect estimate with confidence interval,…
- DRESDAIndependent statistical analysis of Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- DRIPSIndependent statistical analysis of Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02919436).
- DRIVE-SHIFTIndependent statistical analysis of Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside…
- Driving After Cervical Spine Surgery: Complete Statistical AnalysisIndependent statistical analysis of Driving After Cervical Spine Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02782923).
- Driving Simulator Study Comparing Two Modes of Presbyopic Correction With Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of Driving Simulator Study Comparing Two Modes of Presbyopic Correction With Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DRMSIndependent statistical analysis of Diabetes Remote Care Management System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01354015).
- Dronabinol in Total Knee Arthroplasty (TKA): Complete Statistical AnalysisIndependent statistical analysis of Dronabinol in Total Knee Arthroplasty (TKA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04734080).
- Drug Drug Interaction of BI 201335 and Tenofovir: Complete Statistical AnalysisIndependent statistical analysis of Drug Drug Interaction of BI 201335 and Tenofovir: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01340196).
- Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients: Complete Statistical AnalysisIndependent statistical analysis of Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Drug Interaction Study of Digoxin and BI 10773: Complete Statistical AnalysisIndependent statistical analysis of Drug Interaction Study of Digoxin and BI 10773: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01306175).
- Drug Interaction Study of Pyronaridine-artesunate & Metoprolol, & Redosing Study of Pyronaridine-artesunate: Complete Statistical AnalysisIndependent statistical analysis of Drug Interaction Study of Pyronaridine-artesunate & Metoprolol, & Redosing Study of Pyronaridine-artesunate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF): Complete Statistical AnalysisIndependent statistical analysis of Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Drug Therapy for Generalized Anxiety Disorder Among the Elderly: Complete Statistical AnalysisIndependent statistical analysis of Drug Therapy for Generalized Anxiety Disorder Among the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00105586).
- Drug Therapy to Treat Minor Depression: Complete Statistical AnalysisIndependent statistical analysis of Drug Therapy to Treat Minor Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00048815).
- Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE): Complete Statistical AnalysisIndependent statistical analysis of Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Drug-Drug Interaction Study Between Colchicine and Atorvastatin: Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study Between Colchicine and Atorvastatin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00960323).
- Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01303445).
- Drug-Drug Interaction Study of Colchicine and Theophylline: Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study of Colchicine and Theophylline: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00983905).
- Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates: Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05064488).
- Drug-Drug Interaction Study of Qualaquin and Midazolam: Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study of Qualaquin and Midazolam: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00785486).
- Drug-Drug Interaction Study to Estimate the Effect of PF-07321332/Ritonavir and Ritonavir on Midazolam in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study to Estimate the Effect of PF-07321332/Ritonavir and Ritonavir on Midazolam in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL): Complete Statistical AnalysisIndependent statistical analysis of DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]: Complete Statistical AnalysisIndependent statistical analysis of DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein: Complete Statistical AnalysisIndependent statistical analysis of DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]: Complete Statistical AnalysisIndependent statistical analysis of DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]: primary endpoint results, effect estimate…
- DS-RivIndependent statistical analysis of Rivastigmine Study in Adolescents With Down Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01084135).
- DSAEKIndependent statistical analysis of Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00744796).
- DSAPIndependent statistical analysis of DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin Alone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DSC2UIndependent statistical analysis of An Online Health Tool About Down Syndrome: Down Syndrome Clinic to You: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DSSIndependent statistical analysis of rTMS and Retraining in Focal Hand Dystonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01738581).
- DSTIndependent statistical analysis of CoolSculpting of the Distal Thigh Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02335749).
- Dual Energy CT as a Noninvasive Method to Screen for Gastroesophageal Varices: Complete Statistical AnalysisIndependent statistical analysis of Dual Energy CT as a Noninvasive Method to Screen for Gastroesophageal Varices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DUAL-1Independent statistical analysis of Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DUARTIndependent statistical analysis of Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder: primary endpoint results, effect estimate with confidence interval, sample-size…
- DUETTEIndependent statistical analysis of Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- DULCISIndependent statistical analysis of CO2-Laser Treatment in Patients With Diabetic Infected Foot Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02677779).
- Dulcolax vs Placebo in Functional Constipation: Complete Statistical AnalysisIndependent statistical analysis of Dulcolax vs Placebo in Functional Constipation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00526097).
- Duloxetine for Chronic Depression: a Double-blind Study: Complete Statistical AnalysisIndependent statistical analysis of Duloxetine for Chronic Depression: a Double-blind Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00360724).
- Duloxetine for the Treatment of Chronic Pelvic Pain: Complete Statistical AnalysisIndependent statistical analysis of Duloxetine for the Treatment of Chronic Pelvic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01451606).
- DUO-EIndependent statistical analysis of Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- DUO-OIndependent statistical analysis of Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients: primary endpoint results, effect estimate with confidence…